PEG10 activation by co-stimulation of CXCR5 and CCR7 essentially contributes to resistance to apoptosis in CD19+CD34+ B cells from patients with B cell lineage acute and chronic lymphocytic leukemia.
Chunsong Hu(Nanchang University), Tan Jinquan, WU Ya-ou, Qian Shen, Kejian Zhang(Cincinnati Children's Hospital Medical Center), Linjei Zhang, Qun Li(Sichuan University), Junyan Liu(Central South University), Xiong Jei, Mingzhen Yang(Anhui Medical University), Baojun Huang, Qun Wu(Northeast Agricultural University), Zhimin Sun, Youxin Jin(Shanghai University), Qiuping Zhang, Gao Qingping(University of Electronic Science and Technology of China)
PubMed
August 1, 2004
Cited by 53
Related Papers
Potent, Orally Active Heterocycle-Based Combretastatin A-4 Analogues: Synthesis, Structure−Activity Relationship, Pharmacokinetics, and In Vivo Antitumor Activity Evaluation
|Journal of Medicinal Chemistry|2002|421
Microenvironment-Responsive Metal-Phenolic Nanozyme Release Platform with Antibacterial, ROS Scavenging, and Osteogenesis for Periodontitis
|ACS Nano|2023|345
VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema
|Journal of Clinical Investigation|2003|262
miR-24 Regulates Apoptosis by Targeting the Open Reading Frame (ORF) Region of FAF1 in Cancer Cells
|PLoS ONE|2010|247
miR-143 inhibits cell proliferation by targeting autophagy-related 2B in non-small cell lung cancer H1299 cells
|Molecular Medicine Reports|2014|97